Emergent Biosolutions Valuation
| 0IGA Stock | 10.00 0.18 1.83% |
At this time, the firm appears to be overvalued. Emergent Biosolutions shows a prevailing Real Value of USD8.07 per share. The current price of the firm is USD10.0. Our model computes the value of Emergent Biosolutions from reviewing the firm fundamentals such as Profit Margin of (0.19) %, shares owned by institutions of 59.91 %, and Current Valuation of 1.07 B as well as analyzing its technical indicators and probability of bankruptcy.
Enterprise Value 1.1 B | Price Sales 0.3923 | Trailing PE 0.0337 |
Overvalued
Today
Please note that Emergent Biosolutions' price fluctuation is moderately volatile at this time. Calculation of the real value of Emergent Biosolutions is based on 3 months time horizon. Increasing Emergent Biosolutions' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Emergent stock is determined by what a typical buyer is willing to pay for full or partial control of Emergent Biosolutions. Since Emergent Biosolutions is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Emergent Stock. However, Emergent Biosolutions' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.0 | Real 8.07 | Hype 10.44 |
The intrinsic value of Emergent Biosolutions' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Emergent Biosolutions' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Emergent Biosolutions helps investors to forecast how Emergent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Emergent Biosolutions more accurately as focusing exclusively on Emergent Biosolutions' fundamentals will not take into account other important factors: Emergent Biosolutions Cash |
|
Emergent Biosolutions Total Value Analysis
Emergent Biosolutions is presently projected to have takeover price of 1.07 B with market capitalization of 44.16 B, debt of 860.2 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Emergent Biosolutions fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.07 B | 44.16 B | 860.2 M |
Emergent Biosolutions Investor Information
About 60.0% of the company shares are owned by institutions such as pension funds. The company had not issued any dividends in recent years. Based on the key indicators related to Emergent Biosolutions' liquidity, profitability, solvency, and operating efficiency, Emergent Biosolutions is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Emergent Biosolutions Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Emergent Biosolutions has an asset utilization ratio of 57.55 percent. This implies that the Company is making USD0.58 for each dollar of assets. An increasing asset utilization means that Emergent Biosolutions is more efficient with each dollar of assets it utilizes for everyday operations.Emergent Biosolutions Ownership Allocation
Emergent Biosolutions retains a total of 50.95 Million outstanding shares. Over half of Emergent Biosolutions' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Emergent Biosolutions. Please watch out for any change in the institutional holdings of Emergent Biosolutions as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.Emergent Biosolutions Profitability Analysis
The company reported the revenue of 1.05 B. Net Loss for the year was (760.5 M) with profit before overhead, payroll, taxes, and interest of 290.1 M.About Emergent Biosolutions Valuation
The stock valuation mechanism determines Emergent Biosolutions' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Emergent Biosolutions based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Emergent Biosolutions. We calculate exposure to Emergent Biosolutions's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Emergent Biosolutions's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 343.9 M | 328.4 M |
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.